M ammalian intestines harbor a large number of bacteria, specifically in the distal intestine, collectively known as the microbiota. In the last decade, an upsurge of studies describing the importance of the gut microbiota in host health and disease has convincingly demonstrated that colonization by diverse and stabilized microbiota is absolutely essential for the proper development of both innate and adaptive arms of the immune system.
A great deal of recent research indicates that the metabolic functions of the microbiota are substantial and comparable in magnitude to those of the liver. The microbiota can, for example, influence the fatty acid composition of the retina and lens of the eye, affect the bone density, and help vascularization of the gut. [1] This bioreactor provides essential nutrients like biotin and vitamin K and digests complex dietary fiber, generating butyric acid, a major source of fuel for the gut epithelia. [2] Eons of coevolution, driven by a common interest, have made the microbiota an immune system partner in the battle against bacterial pathogens. Specifically, the microbiota functions as an entrenched competitor for food, space, and anchorage sites, thus competitively excluding the invading enteropathogens (colonization resistance). Conversely, two recent studies indicate that the microbiota facilitates successful transmission of pathogenic viruses, [3, 4] and multiple murine models of inflammatory disease, from colitis to arthritis, require a gut microbiota. Further, that the composition of the microbiota is a determinant of disease severity indicates that the microbiota can also constitute a major threat to its host.
Maintaining the homeostasis of such a complex ecosystem has necessitated the development of a specialized "mucosal immune system" (MIS) that expediently detects and clears transient pathogens while also keeping beneficial opportunists on the correct side of the gut epithelial monolayer. In other words, there is a continuous crosstalk between epithelia and the microbiota in such a way that epithelia are well prepared to respond to any invasion by virtue of their ability to secrete a plethora of immune cell
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Dr. Matam Vijay-Kumar chemoattractants (analogous to "To make peace, prepare for war"). As this must be done while minimizing harm to beneficial microbes and host tissues, the MIS has developed an intricate system of communication with the microbiota, largely mediated by toll-like receptor (TLR) and nucleotide oligomerization domain-like receptor (NLR) pattern recognition receptors (PRRs). It appears that both the innate and adaptive immune systems have evolved to require microbial interactions for their proper development, [5] [6] [7] as schematically represented in Figure 1 . Supporting this notion, germ-free mice have reduced gut secretory immunoglobulin A (sIgA), defects in development of gut-associated lymphoid tissues, and smaller Peyer's patches and mesenteric lymph nodes. [8] In this review, we describe the recent advances in the mammalian MIS, focusing on the interplay between innate and adaptive immune cells and their effector molecules in the homeostasis of the microbiota, maintenance of tolerance, and mounting an appropriate inflammatory/immune response against an insult/invading pathogen.
Physical and chemical barriers in the gut
The mammalian gut is the primary site of interaction between the host immune system and the luminal contents, including not only food-derived antigens and toxins but also the microbiota. [9] Mucosal immunity begins in the epithelium when microbes encounter the host at mucosal epithelial surfaces while attempting to colonize and establish themselves. The majority of these microbes and their metabolites are excluded from internal access to the host by both physical and chemical barriers. The physical barriers include a single layer of epithelial cells, their intercellular tight junctions, and the mucus that covers the epithelial surface. [9] Further, the physical barrier is well supported by a delicate balance of chemical barriers such as acidity (low pH), detergents (bile salts), proteolytic enzymes (trypsin), cell wall degrading enzymes (lysozyme), and antibacterial proteins (defensins, etc.) that keep the microbial population in check. In addition, the unidirectional peristaltic movements of the intestine also aid in preventing entry of microbes from the dense distal gut contents to the small intestine.
Mucus layer: Lubricating and trapping barrier
The mucus layer covering epithelial surfaces lubricates the intestinal tract. It displays a sticky gel-forming ability due to its rigid protein structure and high cohesion. Mucus can be regarded as the first line of intestinal physical defense against microbial pathogens, helping in trapping the perturbing microbe. [10, 11] Mucins, the major components of the Mucosal immune system in the gut. In the normal state, PRR-microbiota interactions result in the secretion of antimicrobial peptides and the development of gut-associated lymphoid tissue (GALT). Crosstalk between microbiota and intestinal immune system elicit homeostatic factors such as IgA and defensins that maintain microbiota homeostasis and epithelial barrier integrity.
mucus layer, are secreted by goblet cells that are interspersed among enterocytes throughout the epithelium. Mucins are high molecular weight (MW) glycoproteins with extensive glycosylation and sugar moieties attached to serine or threonine residues by O-glycosidic bonds. Changes in mucin composition might underlie the etiology of some diseases like ulcerative colitis and Helicobacter pylori gastritis. [12] It is now well established that mucins have also a more direct role in combating pathogens and parasites, playing an important part in the coordinated immune response to infection. [13, 14] They also serve as an attachment site for microorganisms by interaction between many bacterial components. However, overexpression of some mucin proteins leads to cancer, [15] while deficiency leads to gut inflammation and colitis (MUC-2). [16] Recently, goblet cells have also been implicated in providing oral tolerance. [17] This study shows that in the steady state, small intestine goblet cells function as passages delivering low-MW soluble antigens from the intestinal lumen to underlying immune cells [CD103 + lamina propria dendritic cells (DCs)]. This preferential delivery of antigens to DCs with tolerogenic properties implies a key role for goblet cells in gut homeostasis. [17] Recently, it has been shown that mice deficient in colonic epithelial specific fatty acid synthase (FAS), unable to acylate MUC-2 with palmitic acid (S-palmitoylation) leading to defective secretion and function, exhibit disruptions in the intestinal mucus barrier as well as increased intestinal permeability, colitis, systemic inflammation, and changes in gut microbial ecology. [18] 
Epithelial barrier: Gate keeper function
The gastrointestinal epithelium forms a critical interface between the internal host and the luminal contents. A majority of the epithelia are absorptive cells (enterocytes) and must also support paracellular and transcellular transport of nutrients, electrolytes, and water. Enterocytes are one of the most rapidly regenerating cells in the body, matched by a high rate of apoptosis allowing for maintenance of epithelial cell homeostasis and permitting the epithelium to heal rapidly following injury. [19, 20] The barrier formed by epithelia must, therefore, be highly regulated and selectively permeable. The stability and function of the epithelial barrier depends on a complex of proteins composed of different intercellular junctions, which include tight junctions (zona occludens and claudins), adherens junctions (E-cadherin and β-catenin), and desmosomes. [21] Accordingly, the permeability to various nutrients varies at individual sites and exhibits regional differences in the specific nutrients and ions transported. Epithelia are also equipped with numerous pumps, which help in maintaining unidirectional/vectorial secretion molecules. Interestingly, mice deficient in the multi-drug resistance 1 (MDR1) pump, involved in pumping several biological molecules, develop spontaneous gut inflammation similar to human inflammatory bowel disease (IBD) that could be prevented by antibiotic treatment. [22, 23] 
Direct innate immune activity of gut epithelia
Beyond serving as a physical barrier to microbes and luminal contents, the epithelium is also known to secrete a variety of molecules, which help in maintaining intestinal homeostasis. In other words, intestinal epithelia can be viewed as "accessory cells" of the MIS. Epithelia secrete an extensive panel of cytokines and chemokines that regulate chemotaxis of immune cells such as neutrophils, macrophages, basophils, and T-cells. [24] The list of epithelial specific effector molecules is growing considerably due to the development of microarray and other sensitive analytical techniques, including germ-free and Cre-recombinase technology, as well as bone marrow chimeras. Cytokine secretion by intestinal epithelial cells (IECs) has been observed in a variety of cell lines, with significant overlap in cytokines secreted by immune cells. Even if their cytokine secretion is less than that of immune cells (e.g. macrophages), the fact that IECs are the most abundant cells at the mucosal surfaces suggests that their level of secretion has an important effect on the local cytokine concentrations. However, the relative contribution of IEC cytokines has not been clearly discerned.
IECs secrete a number of chemotactic cytokines (chemokines) that direct the chemotaxis and thus control the mucosal populations of both innate and adaptive immune cells. Epithelial-derived chemokine interleukin-8 (IL-8, CXCL8; mouse equivalent keratinocyte-derived chemokine, KC) [25] and epithelial neutrophil chemoattractants, including epithelial neutrophil attractant-78 (ENA-78, CXCL5), [26] Gro-a (CXCL1), and Gro-b (CXCL2), [27] regulate neutrophil chemotaxis. For instance, secretion of ENA-78 is considerably delayed but longer lasting than that of IL-8, suggesting a distinct role of these chemokines in responding to pathogens or inflammatory stimuli. Epitheliasecreted chemokines, including monocyte chemotactic protein (MCP-1; CCL2), macrophage inflammatory protein (MIP1α; CCL3) and RANTES/CC L5 (regulated upon activation, and presumably secreted), primarily regulate the monocyte recruitment. MIP1α appears to play a major role in the recruitment of mucosal DCs. [27] The IEC also secretes chemokines that drive recruitment of various T-cell subpopulations in the mucosa. These chemokines are critical for directing the recruitment of intraepithelial lymphocytes (IELs) and include interferon inducible protein (IP-10), monokine induced by interferon (IFN)-γ (Mig), and IFN-inducible T-cell α-chemoattractant (I-TAC). [28] Unlike neutrophils, mucosal IELs are normally present in the mucosa, consistent with the observation that T-cell chemoattractants are constitutively expressed.
Beyond orchestrating the recruitment of a variety of immune cells, the IECs also secrete a number of proinflammatory cytokines, with tumor necrosis factor (TNF)-α and IL-6 being the best examples. [30, 31] The secretion of these cytokines affects the local inflammatory state, and also exhibits a substantial effect over systemic cytokine levels. For instance, TNF-α is not only a potent amplifier of other proinflammatory cytokines and chemokines, but also primes IECs to produce proinflammatory enzymes inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and activates neutrophils to generate more reactive oxygen species (ROS) and degranulation when encountering pathogenic stimuli. These IECs' innate immune activity, in cooperation with professional immune cells, can have substantial influence on both microbiota and host tissue homeostasis.
In addition to the soluble immunomodulators, the IECs also regulate a variety of adhesion molecules that influence the interaction of epithelium with infiltrating immune cells. IEC expression of neutrophil ligands is thought to play a major role in regulating adherence and transepithelial migration (diapedesis) of neutrophils. Specifically, key roles of epithelial CD47 and signal regulatory protein (SIRP) 1a in regulating neutrophil transmigration have been demonstrated. [32, 33] Intracellular adhesion molecule 1 (ICAM-1) is markedly upregulated in inflammatory conditions and possibly plays a role in increased neutrophil-epithelial adherence associated with IBD. [34] IECs are also known to secrete soluble receptors which can neutralize the bioactivity of proinflammatory cytokines. For instance, inflammasome activation results in the secretion of potent proinflammatory cytokines IL-1β and IL-18. The biologic activity of inflammasome cytokines is finely regulated by the expression of endogenous, constitutively expressed soluble inhibitor proteins. Indeed, the absence of these anti-cytokines results in uncontrolled inflammation that causes tissue damage to the host. [35] A well-studied example of regulation of inflammasome cytokines is the secretory IL-1 receptor antagonist (sIL-1Ra), which competes with IL-1β for its receptor, thus dampening the bioactivity of this potent proinflammatory cytokine. IEC sIL-1Ra expression can be induced by proinflammatory stimuli, such as IL-1β itself and lipopolysaccharide (LPS), as well as by a variety of immunomodulators such as granulocyte-macrophage colony-stimulating factor (GM-CSF), IFN-β, IFN-γ, and flagellin. [36] [37] [38] Importantly, sIL-1Ra is much more broadly expressed than IL-1β, allowing cells that do not make IL-1β to have a role in regulating its activity. Similarly, epithelia can induce IL-18 binding protein (IL-18BP) in response to the proinflammatory cytokine IFN-γ, which is a potent inhibitor of IL-18. [38] A key aspect of the epithelium's role in the MIS is its ability to finely regulate immune cell function and activation. Therefore, activation and return to the normal state should be tightly linked. For instance, the inability to recruit immune cells rapidly in response to pathogens would make the host more susceptible to systemic infection (e.g. MyD88-deficient mice, discussed below). Conversely, excessive and uncontrolled recruitment, especially of neutrophils, is likely to be detrimental because it can lead to substantial damage of host tissue, as observed in chronic IBD. Thus, IECs exert tight control over their immune-modulating genes of the MIS, especially those associated with immune cell recruitment, such as the neutrophil chemoattractant IL-8.
Microfold cells
Another structurally distinct epithelial cell type is the microfold (M) cells, characterized by a microfolding plasma membrane. These cells are immunologic sentinels playing an important role in mucosal adaptive immunity. [39] They are considered as specialized epithelia and are present over the surface of the B-cell follicles [Peyer's patches and isolated lymphoid follicles (ILFs)]. They are the principle cells responsible for sampling intestinal microbiota and pathogens. [40] Structurally, M-cells have shorter/scanty microvilli and much less glycocalyx on their surface, unlike other enterocytes, which help them to pick up particles from the lumen and funnel them to the lymphoid tissues on their basolateral sides. Owing to this nature, these cells have emerged as a center point in the development of oral vaccines. [41] However, they are also among the most exploited cell types in the lumen by several pathogens (e.g. Salmonella typhimurium, Yersinia spp, adherent-invasive Escherichia coli, reoviruses) to facilitate their invasion. [42] [43] [44] Recently, "villous" M cells have been reported, which are present on the villous epithelium of the small intestine and share functional and structural characteristics of normal M cell but lack any lymphoid association. [45] 
Paneth cells
Another important component of the MIS is "Paneth cells," named after Josef Paneth. These columnar cells have prominent granules and reside at the base of the crypts of Lieberkühn in the small intestine. Each crypt contains approximately 15 stem cells and 10 Paneth cells. Occasionally, Paneth cells are also present in the stomach and colon as a metaplastic response to gut inflammation. Unlike IECs, which have a life span of 3-5 days, Paneth cells live relatively longer (>30 days). These cells have large apical defensin-rich secretory granules, which are released into narrow epithelial crypts via exocytosis (i.e. merocrine secretion) in response to various stimuli that include bacterial products but not those of fungi or protozoa. Human Paneth cells express two alpha-defensins: Human defensin 5 (HD5) and human defensin 6 (HD6). [46] They also secrete lysozyme, secretory phospholipase A2, and regenerating islet-derived protein III-alpha (RegIIIA). [47] However, unlike humans, mice and rats express more than two alpha-defensins. Mouse Paneth cells also secrete numerous cryptdin-related peptides and an RNase, angiogenin 4 (for further details see Ref. [47] ). Defensins are synthesized as prepropeptides, which are eventually processed by Paneth cell trypsin in humans and matrix metalloproteinase-7 (MMP-7) in mice. [48] Data from experimental animals indicate that defensins make up around 15% of the total antimicrobial activity of the gut in both germ-free and conventional mice [49] and the concentration of defensins in crypts can reach >10 mg/ml. [50] Intestinal macrophages Macrophages (MΦ) are one of the most abundant leukocytes in the subepithelial lamina propria of mammals, and this population likely makes up the largest macrophage reservoir in the body. The number of MΦ in different locations of the intestine seems to be closely associated with the relative microbioal load, and they are thus highest in the large intestine and least in the intestines of germ-free mice. Given that IBD is believed to be driven by aberrant immune response to commensal microbiota, which are present in large quantities in the normal colon, and that MΦ are constantly present there, it is intriguing to consider why the intestine is not in a permanent state of inflammation. [51] It has been shown in numerous studies that unlike MΦ from other tissues, mucosal MΦ do not respond to TLR ligands by secreting proinflammatory cytokines or chemokines such as IL-12, IL-23, TNF-α, IL-1, IL-6, or CXCL10 (IP-10) nor do they up-regulate co-stimulatory molecules or generate ROS and nitric oxide (NO) production under these conditions. [51] They do, however, synthesize IL-10 (a major anti-inflammatory cytokine) constitutively or in response to TLR ligands. [52, 53] Further, resident gut MΦ are highly phagocytic and express CD36, a receptor that facilitates phagocytosis of apoptotic cells. [51] They also exhibit strong bactericidal activity without initiating overt inflammation, allowing local MΦ to act as a firewall against any commensal bacteria that breach the epithelial barrier. They do not express high levels of co-stimulatory molecules such as CD80, CD86, or CD40, but they do express cytosolic PRRs, which are critical for their antibacterial activity. [54] In addition, the resident intestinal MΦ do not only contribute to gut homeostasis by acting as a waste disposal unit for local bacteria and dead cells, but also actively regulate epithelial integrity. As a result, depletion of resident MΦ increases susceptibility of mice to experimentally induced colitis. [55, 56] Expression of the transcription factor peroxisome proliferator-activated receptor-γ (PPAR-γ) by mucosal MΦ is an alternate mechanism by which they can prevent local inflammation, via its ability to suppress proinflammatory gene expression. [57] Thus, MΦ in the MIS can be viewed as a functional subset involved in the normal physiological processes of tissue remodeling and avoiding immune response to commensal microbes.
The accumulated data indicate that most of the immune cells in the MIS are capable of constitutive IL-10 secretion. It is worth mentioning that deletion of IL-10 results in the development of spontaneous colitis. [58] In addition, inhibition of IL-10 signaling in myeloid cells via targeted deletion of signal transducer and activator of transcription 3 (STAT3) results in spontaneous colitis. [59] Clearly, IL-10 is a critical
Intestinal T lymphocytes
T-cells are one of the most abundant leukocytes in the subepithelial lamina, and are important players in mammalian gut immunity as highlighted by the dramatic consequences of their absence, such as human immunodeficiency virus (HIV) infection. Germ-free mouse lamina propria is devoid of T-cells, with only primary follicles in Peyer's patches. [60, 61] Following colonization with bacteria, the mucosal T-cell population rapidly increases to a normal level as seen in conventional mice, demonstrating that microbial antigens or products are necessary for maintaining the T-cell population. In general, the T-cell population in healthy animals is principally composed of type 1 T helper (TH1) and type 2 T helper (TH2) cells. While Crohn's disease is associated with a TH1 cytokine profile, ulcerative colitis is TH2 biased. [62] This concept has been further complicated by the description of tolerizing regulatory T-cells (Tregs) and by proinflammatory TH17 cells, a novel T-cell population characterized by the master transcription factor RAR-related orphan receptor gamma (RORγt), and the surface markers IL23R and C-C chemokine receptor type 6 (CCR6).
[62] TH17 cells differentiate under the influence of IL1β, IL6, IL21, IL23, and transforming growth factor beta (TGF)-β. [63] [64] [65] TH17 cells are known to secrete proinflammatory cytokines IL17A, IL17F, IL21, IL22, and IL26, and the chemokine CCL20, and several studies demonstrated an important role of TH17 cells in intestinal inflammation, particularly in Crohn's disease. [62] TH17 cells play a central role in the neutralization of pathogens and commensal microbiota, both by coordinating neutrophil influx and by maintenance or restitution of epithelial barrier integrity via IL17 and IL22 synthesis. Interestingly, mucosal epithelia express receptors for these TH17 cytokines, promoting tight junction formation, antimicrobial peptide production, as well as mucus production.
Intestinal DCs
DCs are the most potent professional antigen-presenting cells (APCs). Unlike macrophages, DCs can initiate the primary immune response by activating naïve T-cells and regulate proinflammatory or tolerogenic immune responses. [66] In addition, DCs also express PRRs for sensing microbial products depending on the environment. DCs are very flexible and able to polarize TH1, TH2, or Treg immune responses depending on their prior exposure to cytokines/microbial ligands. Once the DCs migrate to the sub-mucosa, they become highly efficient in sampling intestinal contents via dendrites for antigen capturing and processing [66] occurring through the epithelial monolayer or M cells. [67, 68] Under physiological conditions, DCs have a regulatory role and prevent immune responses against food antigens and gut microbiota. [66] They attain a regulatory profile by various signals [thymic stromal lymphopoietin (TSLP), IL-10, TGF-β], more specifically by retinoic acid (RA), an active form of vitamin A. In the presence of RA, intestinal DCs (but not DCs in other tissues) acquire the ability to generate Tregs and IgA-secreting B-cells using enzymes that convert vitamin A into RA. [69] Intestinal DCs can be distinguished from other tissue DCs by (i) decreased expression of PRRs, (ii) reduced expression of co-stimulatory molecules, and thus, reduced antigen presentation, (iii) higher production of anti-inflammatory cytokines (IL-10), (iv) favoring differentiation of antigen-specific Tregs and IgA secretory B-cells, and (v) inducing immune tolerance via the expression of gut-homing markers both in Tregs and IgA-secreting B-cells. Any changes in the above characteristic features of intestinal DCs result in an aberrant immune response toward the microbiota, possibly leading to IBD.
Innate lymphoid cells
Innate lymphoid cells (ILCs) are the more recently discovered innate immune cells in the MIS [70, 71] that are defined by the lack of specific antigen receptors and play a central role in the regulation of gut epithelial cell barrier integrity, and of immunity, inflammation, and tissue repair in the intestine.
[72] ILC depletion using a mouse model of non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) IL-2 receptor common gamma chain double-deficient mice [71] results in peripheral dissemination of commensal bacteria and systemic inflammation, which was rescued by administration of IL-22, suggesting that IL-22 produced by these cells plays a key role in maintaining barrier function. [73] 
Secretory IgA
The most abundant adaptive immune factor in the intestinal lumen is sIgA, which plays a major role in intestinal homeostasis. It is mainly secreted as a dimer and covalently associated with epithelial glycoprotein secretory component. Subepithelial B-cells in the intestine secrete IgA, which translocates via the epithelial monolayer and whose subsequent secretion into the intestinal lumen represents a major immunological barrier. [74] The major functions of sIgA include (i) protection against enteropathogens (e.g. Salmonella, rotavirus), (ii) providing herd immunity against horizontal fecaloral spread of enteropathogens, and (iii) limiting the spread of intestinal-derived antigens into the circulation (see Ref. [75] for details). The luminal sIgA plays a prominent role in protecting against Vibrio cholera and enterotoxigenic E. coli. Also, the host microbiota plays a key role in IgA secretion, as it has long been known that gnotobiotic mice display strikingly reduced levels of sIgA in their feces.
IECs, which are in close proximity with the microbiota, play a role in the process of IgA secretion. The best example is that the development of ILFs from cryptopatches is dependent on sensing of the microbiota by nucleotide-binding oligomerization domain protein 1 (NOD1), which results in the secretion of the B-cell chemoattractant CCL20 by IECs. ILFs are the predominant sites for sIgA production in a T-cell independent fashion. Inflammation of the intestine substantially increases sIgA secretion into the lumen. For instance, mice expressing a constitutively active form of TLR-4 lacked spontaneous colitis, but showed an increase in B-cell recruitment and trophic factor production, leading to an increase in the production of sIgA. [76] In addition to influencing B-cell recruitment, IECs have been shown to constitutively produce factors that directly stimulate IgA production via production of IL-6, and induce B-cell IgA 2 class-switching via stimulating a proliferation-inducing ligand (APRIL). Innate immunity signaling via TLR also augments the transit of sIgA into the lumen, as exposure of IECs to LPS or heat-inactivated E. coli leads to increased expression of the polymeric Ig receptor, which binds to subepithelial IgA and shuttles it across epithelia. Even though several studies indicate that DCs that have sampled luminal antigens are a driving force behind the secretion of sIgA, microbe-exposed epithelia can also influence this process, further highlighting the importance of IECs in the MIS. Tregs also play a role in the induction of sIgA, and the induction of Tregs coincides with a powerful induction of sIgA [77] upon microbiota colonization. Both humans and mice that selectively lack IgA exhibit weak symptoms since IgM can compensate for IgA deficiency. [78, 79] The microbiota helps to develop the host MIS The mammalian intestines are inhabited by a large, diverse community of microbes, which are collectively Biomed J Vol. 37 No. 5 September -October 2014 known as the gut microbiota; it contains approximately 10 14 bacteria, weighing 1-2 kg, and comprises 6-10 major phyla and about 3000 species. [80] The composition of the microbiota is thought to remain stable throughout the life of the host, even when there are drastic changes in the diet and level of physical activity, during pregnancy, and with the use of broad-spectrum antibiotics. [81, 82] Interestingly, "germ-free" (also referred to as gnotobiotic) mice, which lack a microbiota, have considerable immune and metabolic defects. [83] However, accumulated data from a variety of immune-deficient murine models indicate that altered microbiota plays a central role in origination of intestinal inflammation and metabolic diseases. [84] Together, these studies suggest that homeostasis of the microbiota is required to maintain a beneficial symbiotic relationship.
For this purpose, the MIS has developed multiple ways to maintain microbiota-host homeostasis and defend against pathogens. PRRs of the innate immune system, particularly the TLRs and NOD-like receptors (NLRs), play essential roles in these processes. Both TLRs and NLRs recognize a variety of broadly conserved microbial components.
Pattern recognition in the gut
Given the potentially overwhelming microbial biomass in the gut and the fact that several PRRs can sense their cognate agonists at picomolar levels, the host has evolved a number of effective mechanisms to prevent constant/ repeated PRR activation while maintaining the ability to activate PRRs when needed, so as to maximize the benefits conferred by microbiotal stability [ Tables 1 and 2] .
Apart from the physical obstacles to activation of PRRs by abundant luminal microbial ligands [ Tables 1 and 2 ], namely the aforementioned thick mucus layer laden with antibacterial compounds, additional mechanisms exist to inhibit aberrant PRR activation in the gut. One such mechanism is for the intestine to be selective about the cell types and the conditions in which TLRs are expressed. For instance, TLRs 2 and 4, receptors for the bacterial cell wall components peptidoglycan and LPS, respectively, are barely expressed in healthy IECs but are upregulated in conditions associated with IBDs. [85] In addition, activation of TLR-4, the most proinflammatory of the PRRs, in IECs is also avoided by limiting the availability of co-receptors, myeloid differentiation factor 2 (MD-2), CD14, and LPS-binding protein. [86] TLRs 2 and 4 are also expressed at greater levels by IECs that have yet to migrate up the villus, ensuring that robust activation of these PRRs occurs only if the crypt, which is not normally colonized, is threatened. [87] Furthermore, the receptor for flagellin, TLR-5, is expressed only on the basolateral side of IECs, a strategy that allows the host to generate a response only to invasive flagellated microbes. [88] TLR-9 is unique among the TLRs in that it is capable of dampening signaling through all TLRs. While basolateral activation of TLR-9 by microbiotal DNA elicits a classical nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) mediated inflammatory response, apical TLR-9 attenuates such a response via an alternative signaling pathway that blunts IL-8 activity, inhibiting neutrophil chemotaxis. [89, 90] In addition, constant exposure to their respective ligands can result in immunological tolerance, a mechanism that may also protect against aberrant inflammation and even autoimmunity. [91] Thus, the innate immune response in the gut may be viewed as preventing the excessive PRR activation that might result if the microbiota was not properly managed. Such tight control over microbiota/PRR interactions serves to limit aberrant inflammation.
In a similar fashion, nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) have evolved in IECs to avoid overactive inflammatory responses toward the resident microbiota and also to preserve epithelial barrier integrity and functions by maintaining homeostasis. Recent studies targeting the intestinal microbiota in the context of NLR deficiencies suggest inherent alterations in bacterial density or abundance may underlie the development of inflammatory diseases. Inflammasomes have emerged as central regulators of intestinal infection, immunity, and inflammation. In addition to mediating intestinal epithelial integrity, antimicrobial responses, and initiating inflammation through generation of the cytokines IL-1β and IL-18, the inflammasome appears to play a pivotal role in the control of intestinal microbiota composition. [92] Inflammasome-deficient mice show an aberrant microbial community, which is dominantly transmissible to healthy mice, leading to the transmission of non-alcoholic fatty liver disease (NAFLD), obesity, intestinal inflammation, and cancer. [93, 94] 
Transcription factors in intestinal immunity
The NF-κB signaling pathway in the gut epithelia is critical not only for the secretion of a myriad of chemoattractants but also for the induction of antimicrobials and proinflammatory enzymes, thus playing a key role in epithelial homeostasis. Accordingly, IEC-specific inhibition of NF-κB through conditional ablation of NF-κB essential modulator (NEMO) (IκB kinase-gamma, essential for NF-κB activation) induces spontaneous chronic intestinal inflammation in mice. [95] NF-κB deficiency led to apoptosis of colonic epithelial cells accompanied by impaired expression of antimicrobial peptides and translocation of bacteria into the mucosa. [95] Concurrently, this epithelial defect triggered a chronic inflammatory response in the colon, initially dominated by innate immune cells but also involving T lymphocytes later. Importantly, deficiency of the gene encoding the adaptor protein MyD88 prevented the development of intestinal inflammation, demonstrating that TLR activation by intestinal bacteria is essential for disease pathogenesis. [95] However, even if TLR activation by gut bacteria is essential for disease pathogenesis, TLR signaling should be viewed more as a beneficial pathway that could also become harmful in an immunodeficiency situation, such as NEMO deletion. Furthermore, activation of TLRs by the microbiota is critical for protection against gut injury and associated mortality, revealing a protective function of TLRs on host-microbial interactions. [96, 97] In addition to NF-κB, several other transcription factors such as T-bet and the STAT family also play a role in gut homeostasis. [98] [99] [100] [101] 
Bacterial metabolites in the development of MIS
Microbiota is known to play a key role in the development of proper gut-associated lymphoid system and gut homeostasis. However, the mechanism by which microbiota-derived signals and metabolites drive gut homeostasis was largely unknown. In a recent study, Smith et al. discovered that short chain fatty acids (SCFAs), such as acetate, butyrate, and propionate, generated via bacterial fermentation of dietary fiber play a key role in the expansion of intestinal but not extra-intestinal lymphoid tissue Tregs. [102] SCFAs specifically increase the number of both in gnotobiotic and conventional mice. In addition, using co-culture experiments, SCFAs were found to improve the inhibitory activity of Tregs on CD4+. [102] In a T-cell adoptive transfer model of chronic colitis, mice pre-treated with propionate alone or SCFAs mix were substantially protected when compared to control mice. In a similar line, Arpaia et al. found that butyrate produced by microbiota facilitated [103] In addition, propionate potentiated de novo Treg generation in the periphery. These studies demonstrate that not only bacterial-associated ligands could participate in the proper development of host MIS, but also their metabolites can profoundly impact the generation of key regulatory cell populations of the adaptive immune system.
Intestinal immunity to non-bacterial organisms
The gut immune system is capable of mounting immune responses not only to bacteria, but also to a variety of protozoan parasites such as Toxoplasma, Entoamoeba, and Giardia, which are increasingly posing a major problem, especially in immunocompromised hosts. [104] While susceptibility to chronic infection is propagated by TH1 cytokine responses (characterized by the production of IL-12, IL-18, and IFN-γ), immunity to intestinal-dwelling adult nematode worms is critically dependent on a TH2 cytokine response (controlled by cytokines IL-4, IL-5, IL-9, and IL-13). Recently, it has been shown that infecting mice with Toxoplasma gondii resulted in microbiota dysbiosis, [105] characterized by a transient enrichment of Enterobacteriaceae belonging to Proteobacteria. The key observation in this study is that T. gondii-infected mice exhibited loss of Paneth cells in the small intestine via mitochondrial damage that was dependent on microbiota, TLR-11, IFN-γ, and MyD88 signaling in CD4+ T-cells. [105] Interestingly, T. gondii-induced microbiota dysbiosis is somewhat similar to the microbiotal alterations observed in animal models of intestinal inflammation and in human IBD, highlighting the opportunistic pathogenic activity of the Enterobacteriaceae family, specifically E. coli. Collectively, this study demonstrates that TLRs not only help preserve microbiotal homeostasis but also effect dysbiosis by damaging the host cells that normally secrete antimicrobial peptides.
Diet and intestinal immunity
Numerous studies have now demonstrated that diet plays a major role in the early development of the gut immune system directly and indirectly. Specifically, in addition to major macronutrients, micronutrients such as vitamins A and D and minerals such as iron can greatly influence the MIS. Recent additions to the list of increasingly notable dietary components are chemicals present in vegetables, specifically of the Brassicaceae family, as well as lactose in milk. Some dietary factors also promote disease pathogenesis, which include milk fat acting as a colitogenic factor in susceptible mice by favoring the growth of a specific bacterium, Bilophila wadsworthia. [106] It has long been known that gluten-rich proteins (wheat, rye) are driving factors in the etiology of celiac disease (CD). Although the contribution of adaptive immunity in CD pathogenesis is well established, evidence on the direct involvement of innate immunity, which is required for 
Conclusion
In conclusion, the mammalian gut immune system should be viewed as a complex interplay between physical, chemical, and cellular barriers, a vast community of bacteria, and plethora of host immune cells which mediate innate and adaptive immunity. The intestinal microbiota helps in proper development of the host immune system, which in turn regulates the homeostasis of the microbiota.
[108] Accumulating evidence over the last decade indicates that the MIS and microbiota interaction should be finely balanced and any perturbations of this interaction would result in microbiotal and immune dysbiosis, leading to inflammatory disorders. The rapid surge in the emerging new-age disorders such as IBD, rheumatoid arthritis, cardiovascular disease, and metabolic syndrome has driven investigators to explore their etiology in multiple directions such as genetics, diet, and environmental factors, as well as MIS-microbiota interactions. In addition, the practice of strict hygienic and sanitary conditions and consumption of highly processed foods containing high fat, high carbohydrate, and low fiber with numerous food additives and preservatives may account for altered microbial composition, metabolism, and interaction with host immunity. Nearly all the above diseases are characterized by local as well as systemic low-grade chronic or sub-clinical inflammation in which the inflammation originated in the intestine via the interaction between host MIS and microbiota. Hippocrates (460-370 BC) stated, "All diseases begin in the gut."
